Case Control Study
Copyright ©The Author(s) 2023.
World J Crit Care Med. Jun 9, 2023; 12(3): 165-175
Published online Jun 9, 2023. doi: 10.5492/wjccm.v12.i3.165
Table 4 Antibiotics sensitivity percentage of the common gram-positive causative organisms for patients with ventilator-associated pneumonia in our study, n (%)
Antimicrobial agent
MSSA, n = 4
MRSA, n = 1
Penicillin0/4 = 0 (0)0/1 = 0 (0)
Oxacillin4 (100)0/1 = 0 (0)
Erythromycin4 (100)1 (100)
Clindamycin4 (100)1 (100)
Tetracycline4 (100)1 (100)
Vancomycin4 (100)1 (100)